⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28126358 | 1.00 | — | — | |
| SCHEMBL24718723 | 0.84 | — | — | |
| SCHEMBL4890557 | 0.67 | HTR6 (0.34) | — | |
| SCHEMBL28104352 | 0.67 | — | — | |
| SCHEMBL28104349 | 0.67 | — | — | |
| SCHEMBL28211406 | 0.62 | — | — | |
| SCHEMBL28211404 | 0.62 | — | — | |
| SCHEMBL9393516 | 0.62 | EPHX2 (0.33) | — | |
| SCHEMBL4456910 | 0.62 | EPHX2 (0.33) | — | |
| SCHEMBL29700 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107976546-A | Inhibition of phosphorylation to TOR kinase inhibiting activities mark PRAS40, GSK3- β or P70S6K1 | 西格诺药品有限公司 | 2018-05-01 | — | — | CN | claimed |
| CN-107474051-A | Pharmaceutical composition, its solid form and their purposes of dihydro pyrazine and pyrazine compound | 西格诺药品有限公司 | 2017-12-15 | — | — | CN | disclosed |
| CN-104093398-B | 7 (6 (2 hydroxy propane, 2 base) 3 base of pyridine) 1 ((trans) 4 methoxycyclohexyl) 3,4 dihydro pyrazines simultaneously [2,3 B] pyrazine 2 (1H) ketone, the pharmaceutical composition of its solid form and its using method | 西格诺药品有限公司 | 2017-03-15 | — | — | CN | disclosed |